Oncology July 2010
Antiangiogenesis Therapy: A New Strategy for Cancer Treatment
Antiangiogenesis therapy represents one of the most significant advances
in clinical oncology.
Vorinostat and Romidepsin for the Treatment of Cutaneous T-Cell Lymphoma
Cutaneous T-cell lymphoma is a heterogeneous group of
non-Hodgkin's lymphomas that are characterized by T lymphocytes
that infiltrate the skin.
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
-
• April 2026 • 2.00 Credits
Managing HIV Coinfections and Complications
-
Pain Management • March 2026 • 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
-
Cardiovascular • February 2026 • 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.